R. Navaridas

发表

Transient, DNA-free in vivo CRISPR/Cas9 genome edition for flexible modelling of endometrial carcinogenesis

X. Dolcet, J. Colombelli, D. Llobet-Navás, 2022, bioRxiv.

M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

N. Eritja, X. Matías-Guiu, R. Martí, 2022, British Journal of Cancer.

ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma

N. Bonifaci, N. Eritja, X. Matías-Guiu, 2021, Molecular oncology.

Involvement of the mitochondrial nuclease EndoG in the regulation of cell proliferation through the control of reactive oxygen species

G. López-Lluch, A. Zorzano, X. Dolcet, 2020, Redox biology.

Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma

E. Garí, X. Dolcet, Neus Colomina, 2022, International journal of molecular sciences.

Transient and DNA-free in vivo CRISPR/Cas9 genome edition for flexible modelling of endometrial carcinogenesis

X. Matías-Guiu, X. Dolcet, J. Colombelli, 2022, bioRxiv.

Tumor suppressive function of E2F‐1 on PTEN‐induced serrated colorectal carcinogenesis

N. Eritja, X. Matías-Guiu, C. Piñol, 2018, The Journal of pathology.

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

N. Eritja, X. Matías-Guiu, A. Yeramian, 2022, Scientific Reports.

Palbociclib has antitumour effects on Pten‐deficient endometrial neoplasias

C. Moiola, E. Garí, N. Eritja, 2017, The Journal of pathology.

Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation

N. Eritja, X. Matías-Guiu, X. Dolcet, 2021, Cancers.

A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

Masatoshi Nomura, Xavier Matias-Guiu, A. Yoshimura, 2017, Cell Death and Differentiation.

T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAFV600E melanoma: TTCCs are therapy target in BRAFV600E melanoma.

R. Sanz-Pamplona, N. Eritja, X. Matías-Guiu, 2019, The Journal of investigative dermatology.

M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

N. Eritja, O. Maiques, A. Macià, 2022, British Journal of Cancer.

ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status

E. Campo, X. Dolcet, M. Llovera, 2021, Cancers.

Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness

N. Bonifaci, E. Garí, A. Villanueva, 2022, Molecular oncology.

In vivo intra-uterine delivery of TAT-fused Cre recombinase and CRISPR/Cas9 editing unveil histopathology of Pten/p53-deficient endometrial cancers

X. Matías-Guiu, A. Yeramian, X. Dolcet, 2023, bioRxiv.

Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer

C. Decaestecker, I. Salmon, I. Ray-Coquard, 2023, Nature.

Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice

A. Yeramian, M. Encinas, J. M. Díaz-Tocados, 2024, bioRxiv.

Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.

A. Yeramian, X. Dolcet, M. Encinas, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.